AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Genuit Group PLC

Declaration of Voting Results & Voting Rights Announcements May 23, 2018

4912_agm-r_2018-05-23_886254a7-0d33-4861-90f6-01bf4e73052d.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0530P

Polypipe Group PLC

23 May 2018

POLYPIPE GROUP PLC

(the "Company")

Results of Annual General Meeting

23 May 2018

Polypipe Group plc announces that at the Annual General Meeting ("AGM") of the Company held today, all the Resolutions contained in the Notice of AGM were duly passed on a show of hands. 

The total number of proxy votes received in respect of each such resolution 48 hours prior to the

meeting is set out below.

Resolution In favour % Against % Withheld / Abstained
1. To receive the audited accounts of the Company for the year ended 31 December 2017 and the Directors' Report and the Auditor's Report 151,932,853 99.62 561,121 0.37 45,191
2. To approve the Directors' Remuneration Policy 127,934,229 87.62 18,067,599 12.37 6,537,337
3. To approve the Directors' Remuneration Report for the year ended 31 December 2017 143,258,256 96.43 5,285,135 3.56 3,989,773
4. To declare a final dividend of 7.5 pence per Ordinary Share for the year ended 31 December 2017 148,331,525 99.49 750,786 0.50 3,456,855
5. To elect Mr Paul James as a Director of the Company 149,570,067 98.05 2,961,919 1.94 7,180
6. To elect Mr Glen Sabin as a Director of the Company 149,469,388 97.98 3,069,138 2.01 640
7. To re-elect Mr Martin Payne as a Director of the Company 149,319,165 97.88 3,219,361 2.11 640
8. To re-elect Mr Ron Marsh as a Director of the Company 136,227,127 91.95 11,903,725 8.04 4,408,313
9. To re-elect Mr Paul Dean as a Director of the Company 150,112,136 98.41 2,417,198 1.58 9,832
10. To re-elect Mrs Moni Mannings as a Director of the Company 144,793,527 96.86 4,674,577 3.13 3,073,062
11. To re-elect Mr Mark Hammond as a Director of the Company 150,370,401 98.57 2,160,933 1.42 9,832
12. To reappoint Ernst & Young LLP as auditor of the Company 152,425,722 99.98 1,186 0.01 114,257
13. To authorise the Audit Committee to determine auditor's remuneration 152,539,340 99.98 1,186 0.01 640
14. To authorise the Directors to allot shares 146,766,747 96.21 5,769,254 3.78 5,165
15. To authorise the Directors to allot shares for cash and to disapply pre-emption rights 152,529,615 99.98 6,386 0.01 5,165
16. To authorise the Directors to allot shares for cash and to disapply pre-emption rights in connection with an acquisition or other capital investment 146,784,764 96.22 5,752,761 3.77 3,640
17. To authorise the Company to make market purchases of its own shares 147,472,720 97.19 4,245,851 2.80 822,624
18. To authorise the Company to call a general meeting (other than an annual general meeting) on not less than 14 clear days' notice 144,102,447 94.46 8,438,340 5.53 379

The total number of shares on the register at close of business on 21 May 2018, being those eligible to be voted on at the AGM, was 199,747,464.

In accordance with Listing Rule 9.6.2 copies of all resolutions passed as Special Resolutions at the AGM will be submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/nsm.

These resolutions will also available on the Polypipe website at http://investors.polypipe.com.

For further enquiries, please contact:

Emma Versluys                                                + 44 (0) 1709 770 000

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RAGEAFSDAAXPEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.